Detalhe da pesquisa
1.
The seventh international RASopathies symposium: Pathways to a cure-expanding knowledge, enhancing research, and therapeutic discovery.
Am J Med Genet A
; 188(6): 1915-1927, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35266292
2.
From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis.
Am J Med Genet A
; 179(6): 1098-1106, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30908866
3.
Cutaneous neurofibromas in the genomics era: current understanding and open questions.
Br J Cancer
; 118(12): 1539-1548, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29695767
4.
2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.
Am J Med Genet A
; 176(5): 1258-1269, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29681099
5.
The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosis.
Am J Med Genet A
; 173(6): 1714-1721, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28436162
6.
NFFinder: an online bioinformatics tool for searching similar transcriptomics experiments in the context of drug repositioning.
Nucleic Acids Res
; 43(W1): W193-9, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25940629
7.
The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway.
Am J Med Genet A
; 170(8): 1959-66, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27155140
8.
The third international meeting on genetic disorders in the RAS/MAPK pathway: towards a therapeutic approach.
Am J Med Genet A
; 167A(8): 1741-6, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25900621
9.
CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.
Am J Med Genet A
; 164A(3): 563-78, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24443315
10.
RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights.
J Invest Dermatol
; 143(8): 1358-1368, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37245145
11.
In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines.
Int J Cancer
; 131(2): E33-44, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22072503
12.
Lessons learned from drug trials in neurofibromatosis: A systematic review.
Eur J Med Genet
; 64(9): 104281, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34237445
13.
Identifying challenges in neurofibromatosis: a modified Delphi procedure.
Eur J Hum Genet
; 29(11): 1625-1633, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903738
14.
Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry.
JCI Insight
; 5(16)2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32814709
15.
Funding community collaboration to develop effective therapies for neurofibromatosis type 1 tumors.
EMBO Mol Med
; 12(1): e11656, 2020 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31793149
16.
KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?
BMC Cancer
; 9: 196, 2009 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-19545421
17.
Update from the 2013 International Neurofibromatosis Conference.
Am J Med Genet A
; 164A(12): 2969-78, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25255738
18.
Neurofibromatosis as a gateway to better treatment for a variety of malignancies.
Prog Neurobiol
; 152: 149-165, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26854064
19.
Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational study.
PLoS One
; 12(6): e0178639, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28644838
20.
Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future.
J Natl Cancer Inst
; 109(8)2017 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29117388